Number, means and (SD) as a function of trial arm and measurement time point for candidate secondary outcome measures in the ReTrain pilot trial
| Data collection time point | ||||||
| Baseline | 6 months* | 9 months* | ||||
| Measures, n, mean (SD) | ReTrain (n=23) | Control (n=22) | ReTrain (n=21) | Control (n=20) | ReTrain (n=21) | Control (n=20) |
| Fatigue Assessment Scale | 23, 27.17 (7.14) | 22, 25.49 (7.44) | 21, 24.05 (6.26) | 19, 24.05 (8.86) | 20, 27.45 (5.95) | 20, 25.83 (9.14) |
| Stroke Self-Efficacy Questionnaire | 22, 72.41 (22.00) | 22, 73.46 (17.87) | – | – | 20, 73.73 (19.63) | 20, 74.40 (16.94) |
| Outcome expectations for exercise scale (Exercise Beliefs) | 23, 3.66 (0.70) | 22, 3.78 (0.52) | – | – | 19, 4.03 (0.59) | 19, 3.73 (0.52) |
| Short Self-Efficacy for Exercise Scale (Exercise Self-Efficacy) | 23, 3.26 (0.92) | 22, 3.32 (0.89) | – | – | 19, 3.32 (0.89) | 18, 3.22 (1.06) |
| Stroke QoL Scale (total) | 22, 3.31 (0.68) | 22, 3.45 (0.69) | – | – | 20, 3.38 (0.70) | 20, 3.63 (0.82) |
| EQ-5D-5L | 22, 0.51 (0.25) | 20, 0.55 (0.24) | – | – | 19, 0.52 (0.24) | 20, 0.62 (0.25) |
| SF-12: physical component | 21, 33.12 (7.22) | 20, 31.83 (6.69) | – | – | 19, 33.74 (6.44) | 19, 33.25 (6.91) |
| SF-12: mental component | 21, 50.10 (7.11) | 20, 50.68 (7.98) | – | – | 19, 50.47 (6.51) | 19, 48.05 (8.45) |
| Modified Caregiver Strain Index (carer burden) | 8, 11.39 (8.03) | 10, 7.40 (7.83) | – | – | 9, 9.89 (7.22) | 6, 9.50 (8.92) |
–, indicates measurement not taken at this time point.
*Postrandomisation.
ED-5D-5L, EuroQol 5 Dimension, 5 Level, measure of health-related Quality of life; Qol, quality of life; ReTrain, rehabilitation training; SF-12, 12 item Short-Form Health Survey; SF-6D, Short-Form, Six Dimension Health Index.